STTK Shattuck Labs, Inc.
Shattuck Labs, Inc. (STTK) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $210.3K.
Where they traded
Last open-market purchase: June 9, 2026 , by SIEGALL CLAY B .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Shukla Abhinav A. | Chief Technical Officer | Sell 10b5-1 | 410 | $7.01 | $2.9K | 86,380 −0.5% of holding | |
| Shukla Abhinav A. | Chief Technical Officer | Sell 10b5-1 | 100 | $7.07 | $707 | 86,380 −0.1% of holding | |
| Pandite Arundathy N. | Chief Medical Officer | Sell 10b5-1 | 30,000 | $7.01 | $210.3K | 136,219 −18% of holding | |
| Shukla Abhinav A. | Chief Technical Officer | Sell 10b5-1 | 23,365 | $7.08 | $165.4K | 86,380 −21.3% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.